Ventricular Tachycardia Ablation in Late-Onset Phenotype Fabry Disease: A Case Report

Clicks: 11
ID: 332154
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #345 of 407 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 407 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Fabry disease is an X-linked lysosomal storage disorder that can cause progressive cardiomyopathy, myocardial fibrosis, conduction disease, and malignant ventricular arrhythmias. Ventricular tachycardia (VT) ablation in advanced Fabry cardiomyopathy is challenging, particularly in patients with extensive scar and left ventricular assist device (LVAD) support. Case summary A 71-year-old man with late-onset Fabry disease, confirmed by endomyocardial biopsy showing myelin body accumulation, reduced α-galactosidase A activity, elevated plasma Gb3, developed severe left ventricular dysfunction, extensive late gadolinium enhancement, LVAD implantation, and complete atrioventricular block requiring dual-chamber pacemaker implantation. He presented with recurrent palpitations and near-syncope. Device interrogation revealed multiple VT episodes, including one episode degenerating into ventricular fibrillation, and surface electrocardiography documented wide-complex tachycardia with right bundle branch block morphology and an inferior axis. An electrophysiological study was performed using an antegrade transseptal left ventricular approach. Intracardiac echocardiography was used to delineate the LV cavity and LVAD position, facilitating safe catheter navigation and mapping while avoiding interference with the LVAD. Endocardial mapping demonstrated diffuse late potentials, low-voltage substrate, and deceleration zones involving the basal-to-mid inferolateral left ventricle. Substrate modification targeting these abnormal electrograms eliminated inducible ventricular premature complexes. No recurrent VT episodes were detected on subsequent pacemaker interrogation. Discussion This case highlights the complex arrhythmogenic substrate of late-stage Fabry cardiomyopathy and the utility of intracardiac echocardiography-guided mapping in patients with LVAD support. Catheter ablation may provide short-term arrhythmia control, but in advanced Fabry disease, its role remains largely palliative.
Reference Key
openalex_W7221553521 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag746
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.